Expectant management of localized prostatic cancer

Laser Therapy in Localized Prostatic Cancer

Prognostic value of IL-6 in localized prostatic cancer.

AIM The usefulness of interleukin 6 (IL-6) and its soluble receptor IL-6sR in the prediction of the biochemical recurrence was evaluated in patients with prostate cancer treated with radical prostatectomy. PATIENTS AND METHODS IL-6 and sIL-6R serum levels were measured in 96 patients with prostate cancer. RESULTS Using the log-rank test, it was evident that patients with preoperative serum ...

Analysis of external radiotherapy for localized prostatic cancer.

From 1968 to 1986, 62 patients with Stage C prostatic cancer were treated at Hiroshima University Hospital. Of these, 33 patients were treated by castration plus DES-DP(hormone therapy alone) from 1968 to 1975. Twenty-nine patients were treated by definitive radiotherapy after castration (combined therapy) from 1976 to 1986. Although the expected survivals of both periods were comparable, the s...

Expectant management of prostate cancer with curative intent.

PURPOSE We updated our experience with a strategy of expectant treatment for men with stage T1c prostate cancer and evaluated predictors of disease intervention. MATERIALS AND METHODS A total of 407 men with a median age of 65.7 years (range 45.8 to 81.5) with stage T1c (99.8%) or T2a (0.2%) prostate cancer suspected of harboring small volume prostate cancer based on needle biopsy findings an...

Localized prostatic cancer in patients submitted to renal transplant.

OBJECTIVE An attempt is made to evaluate the incidence of prostate cancer in patients who have previously undergone a kidney transplant surgery and to determine the best therapeutic approach to this target group. MATERIAL AND METHODS All kidney transplant male patients over 40 years of age were studied with respect to diseases unrelated to the transplants, which later affected them, mainly fo...